| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. | J Clin Oncol | 2002 | 1.50 |
| 2 | Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. | Transl Res | 2011 | 1.22 |
| 3 | Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues in NSCLC cells. | Mol Cancer Ther | 2011 | 0.78 |
| 4 | O6-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma. | J Pediatr Hematol Oncol | 2003 | 0.75 |